PEOPLE - Enzo Biochem makes appointment:
This article was originally published in Clinica
Enzo Biochem has named Marcus Conant, a professor at the University of California Medical Center, to its board of directors. Mr Conant's appointment at the Farmingdale, New York-based biotechnology company, which specialises in genetic and immune regulation technologies for diagnostic and therapeutic applications, brings the number of board members to eight.
You may also be interested in...
Diagnostics company Bodysphere had to retract an announcement that it had received an emergency use authorization from the US FDA for a COVID-19 serologic test. See why Bethany Hills, an attorney with law firm Morrison & Foerster, says this may be a cautionary tale for other manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.